블로그

• [U.S. FDA] FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with R For Immediate Release June 15, 2026 On June 12, 2026, the U.S. have been recently diagnosed with Stage 3 type 1 diabetes (T1D). blog.naver.com · 2026.06.16